Preclinical Testing of FDA-Approved Drugs Repurposed for Potential Novel Tocolytic Use.

被引：0
|
作者：
Siricilla, Shajila [1 ]
Hansen, Christopher J. [2 ]
Staub, Jeremy D. [1 ]
Walker, Jordan [2 ]
Brown, Alexus J. [1 ]
Benjamin, John [1 ]
Herington, Jennifer L. [1 ,2 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Nashville, TN USA
来源：
REPRODUCTIVE SCIENCES | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
T-018
引用
收藏
页码：119A / 120A
页数：2
相关论文
共 50 条
  • [1] Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases
    Xu, Kui
    Cote, Timothy R.
    BRIEFINGS IN BIOINFORMATICS, 2011, 12 (04) : 341 - 345
  • [2] Repurposing FDA-Approved Drugs for Novel Tocolytic Use in Mono and Combination Therapy to Mitigate Preterm Labor
    Siricilla, Shajila
    Hansen, Christopher J.
    Walker, Jordan A.
    De, Debasmita
    Crockett, Stacey L.
    Herington, Jennifer L.
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 71 - 72
  • [3] Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?
    Kufreobong E. Inyang
    Joseph K. Folger
    Geoffroy Laumet
    Journal of Neuroimmune Pharmacology, 2021, 16 : 531 - 547
  • [4] Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?
    Inyang, Kufreobong E.
    Folger, Joseph K.
    Laumet, Geoffroy
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2021, 16 (03) : 531 - 547
  • [5] Repurposing FDA-approved drugs as potential PARP inhibitors
    Eznarriaga, Maria
    Rahman, Taufiq
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2516 - 2516
  • [6] In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease
    Akkaya, Didem
    Seyhan, Gokce
    Sari, Suat
    Barut, Burak
    DRUG DEVELOPMENT RESEARCH, 2024, 85 (03)
  • [7] Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles
    Sara Tucker Edmister
    Thaís Del Rosario Hernández
    Rahma Ibrahim
    Cameron A. Brown
    Sayali V. Gore
    Rohit Kakodkar
    Jill A. Kreiling
    Robbert Creton
    Scientific Reports, 12
  • [8] Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles
    Edmister, Sara Tucker
    Hernandez, Thais Del Rosario
    Ibrahim, Rahma
    Brown, Cameron A.
    Gore, Sayali, V
    Kakodkar, Rohit
    Kreiling, Jill A.
    Creton, Robbert
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs
    Vivot, Alexandre
    Boutron, Isabelle
    Ravaud, Philippe
    Porcher, Raphael
    GENETICS IN MEDICINE, 2015, 17 (09) : 733 - 738
  • [10] Safety of FDA-Approved drugs - Reply
    Friedman, MA
    Woodcock, J
    Lumpkin, MM
    Shuren, JE
    Hass, AE
    Thompson, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2297 - 2298
12345